Funds Holding Auxilium Pharmaceuticals, Inc.

 
Fund Quotes for Funds Holding Auxilium Pharmaceuticals, Inc. top ^
  • Holdings: Christopher & Banks Corp , Glacier Bancorp Inc , Auxilium Pharmaceuticals Inc , HMS Holdings Corp , KYTHERA Biopharmaceuticals Inc ,
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for ffscx investment picks
  • Holdings: Christopher & Banks Corp , Glacier Bancorp Inc , Auxilium Pharmaceuticals Inc , HMS Holdings Corp , KYTHERA Biopharmaceuticals Inc ,
  • Category: Small Growth
  • Morningstar Rating: 2 Stars
Sign-up for fscmx investment picks
  • Holdings: Christopher & Banks Corp , Glacier Bancorp Inc , Auxilium Pharmaceuticals Inc , HMS Holdings Corp , KYTHERA Biopharmaceuticals Inc ,
  • Category: Small Growth
  • Morningstar Rating: 1 Stars
Sign-up for ffhix investment picks

 
Stock Quotes for Auxilium Pharmaceuticals, Inc. top ^
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for auxl investment picks
  • Industry: Drug Manufacturers - Specialty & Generic
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for auxl investment picks

 
News Articles for Auxilium Pharmaceuticals, Inc. top ^
- Expected to Reduce Annual Operating Expenses by At Least $75 Million - - Focus on Targeted R&D Spend, Consolidated Commercial Operations, Improved Manufacturing Efficiency and Streamlined G&A Expenses - CHESTERBROOK, Pa.
Sign-up for Auxilium Pharmaceuticals, Inc. Announces Corporate Restructuring Designed To Streamline Operations, Maximize Cash Flow And Drive Sustainable Earnings Growth investment picks
Study Results of Concurrent CCH Injections to Treat Two Dupuytren's Contracture Cords with Delayed Finger Extension Selected for Best Paper Session; Data Support Safe and Effective Use of CCH for Treatment of Two Affected Joints Concurrently CHESTERBROOK, Pa.
Sign-up for Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting investment picks
Mid and High Level Doses Demonstrate Statistically Significant Improvement in Cellulite Across All Endpoints; Nearly 70% of Mid and High Dose Patients Satisfied or Very Satisfied with Results CHESTERBROOK, Pa.
Sign-up for Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite investment picks
VANCOUVER, British Columbia, Sept.
Sign-up for QLT Provides Update on Merger With Auxilium Pharmaceuticals, Inc. investment picks
- Endo's Proposal Provides Auxilium Shareholders with Substantial Premium, Immediate Cash Value, and Ongoing Participation in Endo's Global Expansion - Combination would Accelerate Endo's Transformation to Leading Specialty Healthcare Company, Expand Platform for Future Organic Growth - Addition of Auxilium's Leading Men's Healthcare Products and Development Portfolio would Significantly Enhance Endo's Branded Pharmaceutical Business - Expected to be Immediately Accretive to Endo's Adjusted Diluted EPS DUBLIN , Sept.
Sign-up for Endo Delivers A Proposal To Acquire Auxilium Pharmaceuticals For $28.10 Per Share In Cash And Stock investment picks
Data Support CCH could be Used to Treat Two Affected Joints Concurrently; Positive Results Presented from Additional Studies Evaluating CCH Retreatment for Recurrent Contracture CHESTERBROOK, Pa.
Sign-up for Auxilium Pharmaceuticals, Inc. Presents XIAFLEX (CCH) Data From MULTICORD And Retreatment Studies At The ASSH Annual Meeting investment picks
VANCOUVER, British Columbia, Sept.
Sign-up for QLT Provides Further Update on Merger With Auxilium Pharmaceuticals, Inc. investment picks
2014/10/9
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Auxilium Pharmaceuticals Inc. (“Auxilium”) (NasdaqGS: AUXL) concerning the definitive merger agreement with Endo Intl.
Sign-up for Auxilium Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate the Buyout by Endo International investment picks
VANCOUVER, British Columbia, Oct.
Sign-up for QLT Announces Merger With Auxilium Pharmaceuticals, Inc. Terminates for Superior Proposal investment picks
- Auxilium Shareholders to Receive $33.25 Per Share - Combination Designed to Create Leading Specialty Healthcare Company with Expanded Platform for Future Growth - Addition of Auxilium's Leading Men's Health Products and Development Portfolio Expected to Significantly Enhance Endo's Branded Pharmaceutical Business - Transaction Expected to be Immediately Accretive - Endo Expects to Generate up to $175 Million of Annual Run Rate Operating Expense Reductions Inclusive of the $75 Million of Reductions Previously Announced by Auxilium DUBLIN and CHESTERBROOK, Pa.
Sign-up for Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion investment picks
2014/10/13
Levi & Korsinsky is investigating the Board of Directors of Auxilium Pharmaceuticals, Inc. (“Auxilium” or “the Company”) (NasdaqGS:AUXL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Endo International.
Sign-up for SHAREHOLDER ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Auxilium Pharmaceuticals, Inc. Regarding the Fairness of the Sale of the Company to Endo International investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Funds Holding Auxilium Pharmaceuticals, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Autozone Inc  |  Next: Funds Holding Avago Technologies Ltd